Clinical Implication of Coronary Artery Calcium Score in Survivors of Out-of-Hospital Cardiac Arrest [0.03%]
心源性猝死幸存者冠脉钙化积分的临床意义
Koichiro Matsumura,Hiromi Kin,Kenichi Fujii et al.
Koichiro Matsumura et al.
Background: The aim of this study was to evaluate the clinical ability of coronary artery calcium (CAC) score to identify acute myocardial infarction (AMI) in survivors of out-of-hospital cardiac arrest (OHCA). Methods and Results: We studi...
Sex-Related Differences in In-Hospital Mortality in Japanese ST-Elevation Acute Myocardial Infarction Patients Presenting to Hospital in the 24 Hours After Symptom Onset - Results From K-ACTIVE [0.03%]
日本K-ACTIVE注册研究：急性ST段抬高型心肌梗死患者入院后30天内性别相关死亡率差异分析
Sakura Nagumo,Hiroyoshi Mori,Atsuo Maeda et al.
Sakura Nagumo et al.
Background: Despite the drastic advances in clinical care for patients with acute ST-elevation myocardial infarction (STEMI), female STEMI patients have higher in-hospital mortality rates than male patients. This study assessed the influenc...
Calciphylaxis Diagnosed on Skin Biopsy in a Patient With Left Posterior Tibial Artery Stenosis [0.03%]
左后胫动脉狭窄患者的皮肤活检诊断出钙化物病理学
Shigeki Kuwasaki,Hiroaki Kawano,Seiji Koga et al.
Shigeki Kuwasaki et al.
Goal-Oriented Sequential Combination Therapy Evaluated Using Cardiopulmonary Exercise Parameters for the Treatment of Newly Diagnosed Pulmonary Arterial Hypertension - Goal-Oriented Therapy Evaluated by Cardiopulmonary Exercise Testing for Pulmonary Arterial Hypertension (GOOD EYE) [0.03%]
序贯联合治疗新诊断肺动脉高压的指导目标——基于心肺运动试验的评估（GOOD EYE研究）
Akihiro Hirashiki,Takahisa Kondo,Shiro Adachi et al.
Akihiro Hirashiki et al.
Background: Many treatment options are available for pulmonary arterial hypertension (PAH), but specific recommendations for long-term treatment are unavailable. We compared prognosis in PAH patients receiving goal-oriented, sequential comb...
Effect of Inferior Vena Cava Filter on Venous Thromboembolism Mortality in Japan - JROAD and JROAD-DPC Registry Analysis [0.03%]
日本下腔静脉滤器置入对肺栓塞死亡率影响的JROAD和JROAD-DPC注册数据分析
Yoshiaki Ohyama,Norimichi Koitabashi,Tetsuya Nakamura et al.
Yoshiaki Ohyama et al.
Background: Previous randomized clinical studies have raised concerns about whether inferior vena cava filter (IVCF) can benefit patients with venous thromboembolism (VTE). The present study therefore investigated whether IVCF are associate...
Effects of Sodium-Glucose Cotransporter 2 Inhibitor on Vascular Endothelial and Diastolic Function in Heart Failure With Preserved Ejection Fraction - Novel Prospective Cohort Study [0.03%]
钠-葡萄糖共转运体2抑制剂对射血分数保留心力衰竭血管内皮和舒张功能影响的新型前瞻性队列研究
Takaaki Sakai,Shinichiro Miura
Takaaki Sakai
Background: Pathogenesis of heart failure with preserved ejection fraction (HFpEF) may involve endothelial dysfunction and abnormal vascular structure. Sodium-glucose cotransporter 2 (SGLT2) inhibitors have beneficial cardiovascular effects...
Utility of 99 mTc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice [0.03%]
99mTc-PYP显像在真实世界中诊断转甲状腺素蛋白心肌淀粉样变性中的应用价值
Yoshitomo Tsutsui,Toru Kubota,Seiya Kato et al.
Yoshitomo Tsutsui et al.
Background: Amyloid transthyretin (ATTR) cardiac amyloidosis has now been recognized as one of the major causes of heart failure, especially in elderly patients. The purpose of the present study was to validate the usefulness of technetium-...
Myocardial Biopsy in a History of Light-Chain Amyloidosis Patient With Serial Cardiac Magnetic Resonance Imaging Not Suggestive of Cardiac Involvement [0.03%]
轻链淀粉样变病史患者的心肌活检检查，磁共振成像未提示心脏受累
Hana Mizutani,Shusuke Fukuoka,Naoki Fujimoto et al.
Hana Mizutani et al.
Safety and Efficacy of Ambrisentan-Phosphodiesterase Type 5 (PDE5) Inhibitor Combination Therapy for Japanese Pulmonary Arterial Hypertension Patients in Real-World Clinical Practice [0.03%]
安立生坦联合磷酸二酯酶5抑制剂治疗日本肺动脉高压患者的真实世界临床实践安全性和有效性研究
Masaharu Kataoka,Toru Satoh,Hiromi Matsubara et al.
Masaharu Kataoka et al.
Background: This retrospective study was conducted to evaluate the safety and efficacy of ambrisentan combination therapy with phosphodiesterase type 5 (PDE5) inhibitors in Japanese patients with pulmonary arterial hypertension (PAH). Metho...
Soluble Neprilysin - Cardiac Function and Outcome in Hypertrophic Cardiomyopathy [0.03%]
可溶性中性肽酶与肥厚型心肌病患者的左室功能及预后关系的研究
Akiomi Yoshihisa,Tetsuro Yokokawa,Yasuhiro Ichijo et al.
Akiomi Yoshihisa et al.
Background: Circulating soluble neprilysin (sNEP) predicts outcome in heart failure (HF) patients with reduced ejection fraction (EF), but not in those with preserved EF. We examined sNEP in patients with hypertrophic cardiomyopathy (HCM), ...